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PBS  Phosphate-buffered saline
DMSO  Dimethyl sulfoxide
TCA  Trichloroacetic acid
SRB  Sulforhodamine B
CI  Combination index
SEM  Standard error of the mean
AlP  Alkaline phosphatase
LOEL  Lowest observed effect level
NOEL  No observed effect level
Introduction
Mycotoxins are toxic compounds produced as secondary 
metabolites by molds. Contamination of food crops may 
occur on the field or post-harvest. This leads to the entrance 
of mycotoxins into the food chain and consequently to a 
potential risk for human health (Bennett and Klich 2003). 
The variety of fungal species capable of producing myco-
toxins is vast, leading to an even larger diversity of over 
300 secondary fungal metabolites already known to pos-
sess toxic properties. Studies on mycotoxin contamina-
tion profiles in feed and foodstuff reveal that compounds 
generally do not occur isolated, but in complex mixtures 
Abstract Mycotoxins are toxic secondary metabolites 
formed by various fungal species that are found as natural 
contaminants in food. This very heterogeneous group of 
compounds triggers multiple toxic mechanisms, includ-
ing endocrine disruptive potential. Current risk assessment 
of mycotoxins, as for most chemical substances, is based 
on the effects of single compounds. However, concern on 
a potential enhancement of risks by interactions of sin-
gle substances in naturally occurring mixtures has greatly 
increased recently. In this study, the combinatory effects 
of three mycoestrogens were investigated in detail. This 
includes the endocrine disruptors zearalenone (ZEN) and 
α-zearalenol (α-ZEL) produced by Fusarium fungi and 
alternariol (AOH), a cytotoxic and estrogenic mycotoxin 
formed by Alternaria species. For evaluation of effects, 
estrogen-dependent activation of alkaline phosphatase 
(AlP) and cell proliferation were tested in the adenocarci-
noma cell line Ishikawa. The estrogenic potential varied 
among the single substances. Half maximum effect con-
centrations (EC50) for AlP activation were evaluated for 
α-ZEL, ZEN and AOH as 37 pM, 562 pM and 995 nM, 
respectively. All three mycotoxins were found to act as par-
tial agonists. The majority of binary combinations, even 
at very low concentrations in the case of α-ZEL, showed 
strong synergism in the AlP assay. These potentiating phe-
nomena of mycotoxin mixtures highlight the urgent need 
to incorporate combinatory effects into future risk assess-
ment, especially when endocrine disruptors are involved. 
 * Doris Marko 
 doris.marko@univie.ac.at
1 Department of Food Chemistry and Toxicology, University 
of Vienna, Waehringer Str. 38, 1090 Vienna, Austria
1448 Arch Toxicol (2017) 91:1447–1460
1 3
(Domijan et al. 2005; Ezekiel et al. 2012; Serrano et al. 
2013; Shephard et al. 2013; Streit et al. 2013). In addition, 
these co-contaminations are not limited to mycotoxins pro-
duced by one certain fungal genus. Accordingly, co-occur-
rence of mycotoxins of different genera, like Fusarium 
toxins and Alternaria toxins, is evident (Sulyok et al. 2010; 
Uhlig et al. 2013; Warth et al. 2012). As the variety of natu-
rally occurring compounds may suggest, specific modes 
of action of mycotoxins and manifestation of their toxic 
effects in humans and animals are highly diverse. Among 
many other mechanisms of toxicity, several mycotoxins are 
known for their mutagenicity and genotoxicity, while oth-
ers may act on cell membrane permeability, inhibit protein 
synthesis, or induce inflammatory responses (Gross-Stein-
meyer and Eaton 2012; Kamyar et al. 2004; Pestka 2010). 
Interestingly, some mycotoxins also possess endocrine dis-
ruptive potential. The most prominent mycoestrogen is the 
Fusarium toxin zearalenone (ZEN) which is capable of 
binding and activating both human estrogen receptors, α and 
β (ER-α, ER-β) due to its structural similarity to the body’s 
own natural hormone 17-β-estradiol (E2). It is described as 
a full agonist for ER-α and a mixed agonist–antagonist for 
ER-β (Kuiper et al. 1998). After absorption, ZEN is partly 
hydroxylated to α- and β-zearalenol (α-ZEL, β-ZEL), which 
are subsequently reduced to α- and β-zearalanol (α-ZAL, 
β-ZAL) and/or conjugated with glucuronic acid during 
phase II metabolism (Frizzell et al. 2015; Warth et al. 2013). 
Studies on the estrogenic activity of ZEN, and its metabo-
lites, revealed that α-ZEL possesses even stronger estrogenic 
properties than ZEN itself, whereas β-ZEL is less active 
(Frizzell et al. 2011; Hagler et al. 1979; Metzler et al. 2010). 
Due to these effects, ZEN induces estrogenic conditions, 
especially in swine, which initially resulted in the discovery 
of this toxin (Coe et al. 1992; McErlean 1952; Stob et al. 
1962). Several studies postulate endocrine disruptive poten-
tial also in humans. ZEN is known to mediate proliferative 
effects on estrogen-dependent cancer cells of the breast or 
the endometrium (Li et al. 2012a). Recent epidemiological 
studies associate ZEN with perturbed breast development 
and increased breast cancer risk; however, these studies con-
centrated on the evaluation of biomarkers in urine which 
only reflects short-term exposure (Bandera et al. 2011; Bel-
hassen et al. 2015). Apart from its estrogenic activity, ZEN 
also holds DNA damaging properties and induces oxida-
tive stress (Abid-Essefi et al. 2004; Gao et al. 2013). These 
effects are supposedly causally connected to cytotoxic 
effects and are diminished by hydroxylation to α-ZEL or 
β-ZEL (Abid-Essefi et al. 2004, 2009). Alternariol (AOH), 
produced by fungi of the genus Alternaria, is another myco-
toxin capable of inducing estrogenic stimuli. However, this 
effect of AOH is predominantly mediated via ER-β, which 
is bound with approximately ten-fold higher affinity than 
ER-α (Frizzell et al. 2013; Lehmann et al. 2006). Similar 
to ZEN, AOH possesses cytotoxic potential and has been 
found to induce oxidative stress and DNA damage (Fehr 
et al. 2009; Tiessen et al. 2013). In vitro estrogenicity and 
cytotoxicity are, in some measure, quite contrary as estro-
genic effects often involve growth stimuli. Supposable cri-
teria to be decisive for the dominant impact are primarily 
the amount of mycotoxin, but also the duration of exposure. 
In vivo, predominant effects may additionally be influenced 
by specificities of target organ tissues concerning available 
estrogen receptors and metabolizing enzymes.
Recently developed innovative LC–MS/MS-based 
multi-toxin methods revealed the common occurrence of 
Fusarium and Alternaria toxins in food and feed (Sulyok 
et al. 2010; Uhlig et al. 2013; Warth et al. 2012). Therefore, 
the importance to evaluate combinatory effects of com-
pounds produced by these genera is evident, as humans and 
animals are constantly exposed to co-contaminated diets. 
Any kind of effect inherent to a mycotoxin, like cytotoxic-
ity, genotoxicity or estrogenicity, may potentially be influ-
enced by interactions with other mycotoxins. Currently, 
insufficient research effort is put into the elucidation of 
mixture-effects involving endocrine disruptive mycotoxins 
despite its great importance regarding consumer’s risk.
The experimental design of this study aims to give a 
detailed profile on the combinatory estrogenic effects of 
the mycotoxin ZEN, its most potent estrogenic metabolite 
α-ZEL, as well as AOH. Wide concentration ranges were 
tested, in order to cover realistic in vivo exposure scenarios 
of low levels in the body, as well as rare conditions of high 
exposure. Massart et al. (2008) reported mean serum lev-
els of ZEN and α-ZEL in girls with precocious puberty of 
about 3 nM and 300 pM, respectively. Unfortunately, spe-
cific serum levels of AOH have not been investigated so 
far. However, mean AOH concentrations of about 50 nM 
were found in bakery products, but also much higher levels 
of about 97 nM in tomato products, 151 nM in sunflower 
seeds and 380 nM in wheat flour were detected (Hickert 
et al. 2016; Zhao et al. 2015). Here, several magnitudes 
below and above these serum levels or concentrations 
found in foodstuff were tested. Well-established tests on 
estrogenic stimuli and proliferation were conducted under 
equal testing conditions, for the detection of transcriptional 
response and cell growth induction, but also to monitor 
possible cytotoxic effects. Our study presents first insights 
into combinatory estrogenic effects of mycotoxins.
Materials and methods
Chemicals and reagents
Cell culture media and supplements were purchased from 
GIBCO Invitrogen (Karlsruhe, Germany). Alternariol, 
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zearalenone, α-zearalenol, 17-β-estradiol, 4-nitrophe-
nylphosphate, diethanolamine and MgCl2 were purchased 
from Sigma-Aldrich (Schnelldorf, Germany). DMSO, Tri-
ton X-100 and Tris were purchased from Roth (Karlsruhe, 
Germany). Trichloroacetic acid was purchased from VWR 
(Radnor, PA, USA). ICI 182,780 was purchased from Toc-
ris (Bristol, United Kingdom). Chemical structures of the 
tested substances are shown in Fig. 1a.
Experimental design
The aim of this in vitro study was to investigate estrogenic 
effects of combinations of AOH with ZEN or its metabolite 
α-ZEL. The estrogen-sensitive human endometrial adeno-
carcinoma cell line, Ishikawa, is a well-suited model sys-
tem for the detection of estrogenic stimuli (Holinka et al. 
1986; Johnson et al. 2007; Lehmann et al. 2006) and was 
chosen as model system for this study. Two assays were 
used to evaluate estrogenic properties. Transcriptional 
response to estrogens was evaluated by assessment of alka-
line phosphatase activity, encoded by a gene, which is tran-
scriptionally activated upon estrogen receptor activation. 
The sulforhodamine B assay (SRB) assay was performed 
to investigate a potential impact on cell growth and at 
high concentrations of mycotoxins, accordingly, cytotoxic 
effects. Incubation conditions of both assays were kept 
equal, to enable a direct comparison of the obtained results.
Preliminary measurements of concentration ranges of 
the natural estrogen hormone E2 as well as AOH, ZEN and 
α-ZEL were taken in the AlP assay. Due to the low solubility 
of AOH, a final concentration of 1 % DMSO in the incuba-
tion solution needed to be applied. For details on measured 
concentrations, see Fig. 1b. The most potent concentration of 
E2, 1 nM, was always tested in parallel and served as positive 
Fig. 1  E2 and selected mycotoxins: estrogenic activity in the alka-
line phosphatase (AlP) assay and impact on the growth of Ishikawa 
cells. a Chemical structures. b Dose–response curves in the AlP 
assay (mean, SEM). c Inhibition of estrogenic effects in the AlP 
assay by co-incubation with the ER receptor antagonist ICI 182,780 
(mean, SEM). d Impact on cellular protein amount determined by 
the SRB assay (mean, SEM). Significant differences to the solvent 
control (DMSO), or significant differences of co-incubations with 
ICI 182,780 to single tested substances are indicated by asterisks. 
All measurements were repeated in at least three independent bio-
logical replicates, each measured in technical triplicates. (*p > 0.05; 
**p > 0.01;***p > 0.001)
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control for estrogenic stimuli. Measurements of 1 % of the 
solvent, dimethyl sulfoxide (DMSO), were taken as solvent 
control. To confirm that effects arise from estrogenic stim-
uli, E2 and most potent concentrations of single substances 
and combinations were co-incubated with 1 µM of the high-
affinity estrogen receptor antagonist ICI 182,780. Inhibition 
of effects by adding ICI 182,780 indicates the involvement 
of estrogen receptors. Sigmoidal dose–response curve fitting 
with Levenberg–Marquardt algorithm was applied on data 
of each single substance. EC50 values and concentrations of 
single substances reaching the half maximum effect of E2 
were extracted from the dose–response curves.
In order to ensure comparability of the data, measure-
ments of combinations were always taken in parallel to 
measurements of respective single substances at exactly 
the same concentrations. To ensure a detailed elucidation 
of combinatory effects between ZEN and AOH or α-ZEL 
and AOH, all concentrations which showed effects as sin-
gle substances (ZEN 10 pM–10 µM; α-ZEL 1 pM–10 µM; 
AOH 50 nM–10 µM) were combined with each other in 
binary mixtures. In addition, combinations in constant 
concentration ratios were measured in order to elucidate 
whether dose–response curves of ZEN and α-ZEL are 
shifted when combined with AOH. Based on the prelimi-
nary measurements, the ratio of 1:250 (ZEN/α-ZEL/AOH), 
which gave highly potent effects in both combinations, was 
chosen for these evaluations. Here, measured concentra-
tions ranged for ZEN and α-ZEL from 10 fM to 40 nM and 
for AOH from 2.5 pM to 10 µM.
Cell culture
The human endometrial adenocarcinoma cell line Ishi-
kawa was purchased from ECACC (Wiltshire, United King-
dom). Cells were cultivated in humidified incubators (37 °C, 
5 % CO2) in phenol red free Dulbecco’s Modified Eagle’s 
Medium containing F-12 Nutrient Mixture (DMEM/F-12) 
and 10 % FBS (Fetal Bovine Serum). For experiments, FBS 
was exchanged by charcoal-dextran stripped FBS, which pro-
vides low levels of hormones. For all assays, 24 h previous to 
incubation, Ishikawa cells were seeded at a density of 15,000 
cells per well into a 96 well plate. Incubation of AOH, ZEN, 
α-ZEL and all tested combinations was conducted for 48 h, at 
a final solvent concentration of 1 % DMSO. Details on tested 
concentrations are indicated in all figures. All measurements 
were taken at minimum in three independent biological repli-
cates, each measured in technical triplicates.
Alkaline phosphatase assay
This assay was conducted as previously described 
(Lehmann et al. 2006) and optimized. After 48 h of incu-
bation, cells were washed three times with PBS, before 
cell lysis was initiated by keeping the cells at −80 °C for 
20 min. Subsequently, the cell lysate was kept at room 
temperature for 5 min. 50 µl AlP buffer (5 mM 4-nitrophe-
nylphosphate, 1 M diethanolamine, 0.24 mM MgCl2, pH 
9.8) was added to each well and was incubated for 5 min. 
Measurements of absorbance were taken at 405 nm, every 
2 min, for 1 h, at 37 °C, with the Cytation 3 Cell Imag-
ing Multi-Mode Reader from Biotek® (Winooski, Vermont, 
USA). The activity of the alkaline phosphatase was calcu-
lated as the slope of the curve, obtained by the measure-
ments monitored over 1 h. Final results were referred to the 
solvent control.
SRB assay
This assay was conducted according to Skehan et al. (1990). 
After 48 h of incubation, 10 µl of 50 % TCA (trichloroacetic 
acid) was added to each well and incubated for 1 h, at 4 °C, 
in the dark, to facilitate the fixation of cells. Subsequently, 
cells were washed four times with H2O. The plate was 
dried at room temperature in the dark, prior to the addition 
of 50 µl of SRB reagent (0.4 % mass concentration SRB in 
1 % acetic acid solution) per well, and further incubation 
for 1 h at room temperature in the dark. Afterward, wells 
were washed twice with H2O and twice with 1 % acetic acid 
solution, before the plate was dried at room temperature in 
the dark. Finally, 100 µl, 10 mM Tris solution (pH 10) was 
added, incubated for 5 min, in the dark, and absorbance 
was measured at 570 nm, using the Victor V3 1240 Multil-
able Counter from Perkin Elmer (Waltham, Massachusetts, 
USA). Final results were referred to the solvent control.
Evaluation of combinatory effects in an estrogenic 
system
Combinatory effects were determined as described previ-
ously by Vejdovszky et al. (2016) with minor adaptions to 
measurements of estrogenic stimuli.
Combination index theorem
For CI evaluation, effects were calculated by the follow-
ing formula, where max is the chosen maximum value of 
3.7, yC is the measurement of the DMSO solvent control, to 
which all data are referred to, and xT is the measured value 
of the tested substance or combination.
According to Chou et al. (1975, 1984), measured effects 
of combinations were evaluated for synergism, antagonism or 
additivity, based on the medium effect equation and the com-
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The equation below specifies the calculation of the combina-
tion index (CI). D1 and D2 represent applied mycotoxin con-
centrations in the combination. Dm and m are two parameters 
determined via the medium effect equation and describe the 
potency and the shape of the dose–response curves of each 
mycotoxin. The actual effect of the combination is termed fa.
A combination index (CI) value of one indicates additive 
effects, whereas a CI < 1 indicates synergism, and CI > 1 
antagonism. A detailed classification of CI values was applied 
according to Chou (2006) and is illustrated in Fig. 3. As sug-
gested by Chou (2006), the most exact evaluation of combi-
natory effects is achieved by measuring combinations in con-
stant ratios, which allows comparing dose–response relations 
of the combination with the single substances based on the 
medium effect equation. CI values can thereby be calculated 
for the whole effect range of the combination and graphically 
displayed in the effect-CI plot.
Statistics
All measurements of combinations, in the AlP assay and 
the SRB assay, were taken in at least three biological rep-
licates, each in technical triplicates. The whole dose range 
of respective single substance was always measured in 
parallel. Significance levels were set to 5 % (#, *p > 0.05; 
##, **p > 0.01; ###, ***p > 0.001). All data were tested for 
normality by Kolmogorov–Smirnov test. Significant differ-
ences of all measurements, compared to the solvent control, 
or to the respective ZEN or α-ZEL concentration effect, 
were evaluated via one-way ANOVA and Bonferroni post 
hoc test. For statistical comparison of all measurements to 
1 nM E2 with and without ICI 182,780, Student’s t test was 
applied. Statistical analyses were performed with Origin-
Pro 9.1 G (Origin Lab, Massachusetts).
Results
Estrogenic stimuli: activation of alkaline phosphatase
Estrogenic effects of single mycotoxins on Ishikawa cells 
(human endometrial adenocarcinoma) were evaluated after 
48 h of exposure, by measuring AlP activity. Sigmoidal 
dose–response curve fitting was performed for each single 
substance. By this analysis, the effective concentration that 
induces 50 % response (EC50), a commonly used measure 
of toxin potency, can be determined. EC50 values for E2, 
α-ZEL, ZEN and AOH were calculated as 41, 37, 562 pM and 











are related to the respective maximum effect level of each sin-
gle substance which indeed vary, as it is apparent in Fig. 1b. 
A direct comparison of EC50 values may therefore not be 
very meaningful. To enable a more reasonable comparison 
of the curves, concentrations of each single substance which 
reach 50 % of the effect of E2 were extracted from the dose–
response curves. Table 1 lists these concentrations in compari-
son with the EC50 values. To confirm that the observed effects 
indeed arose from estrogenic stimuli, most potent concentra-
tions of all substances were co-incubated with the high-affin-
ity estrogen receptor antagonist ICI 182,780. Corresponding 
results, shown in Fig. 1c, demonstrated that the effects of all 
substances can be suppressed by ICI 182,780 and are therefore 
considered to depend on estrogen receptor activation.
The maximum induction of AlP activity, measured in 
this experimental setup, was not reached by any single 
substance, not even by the human hormone E2. At its most 
potent concentration of 1 nM, E2 reached a mean induc-
tion of 3.2-fold compared to the solvent control. This 
value was defined as 100 %. The maximum induction of 
AlP activity in this system was measured in combination 
tests of 10 nM ZEN and 5 µM AOH, which was on average 
3.4-fold higher compared to the solvent control. Several 
other combinations of ZEN and AOH, but also of α-ZEL 
and AOH, showed effects which also exceeded the effect 
of 1 nM E2 (see Fig. 2i–iv) . However, these findings were 
not statistically significant to measurements of 1 nM E2 
(p < 0.05). All measured effects of single substances and 
combinations are reported in the heatmaps A (ZEN) and B 
(α-ZEL) in Fig. 2. Results are expressed as percentage of 
induction, where 0 and 100 % represent the values of the 
solvent control and of 1 nM E2, respectively. Significant 
AlP activation, compared to solvent control, is indicated by 
asterisks. The color code of these heatmaps indicates the 
strength of the effect, which enables a visual interpretation 
of results of all tested combinations. AOH was found to 
increase the estrogenic effects of both Fusarium toxins in 
almost all tested concentrations. Only AOH in concentra-
tions below 2.5 µM in combination with ZEN below10 nM 
did not increase AlP activity significantly. Some combi-
nations of α-ZEL below 100 pM and AOH below 1 µM 
Table 1  EC50 values and concentrations of single substances reach-
ing 50 % of the effect of E2
a Concentration that gives 50 % of the maximum effect level of each 
single substance
b Concentration that gives 50 % of the effect of 1 nM E2
EC50a 50 % effect of E2b
AOH 995 nM 2.251 nM
α-ZEL 37 pM 55 pM
ZEN 562 pM 1.423 nM
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were found to show significant induction of AlP activity. 
Both data sets, the combinations of AOH with either ZEN 
or α-ZEL, showed similar trends. Effects were most pro-
nounced at somewhat medium concentrations, but decrease 
at very high doses. Concentrations of 0.5–2.5 µM of AOH 
were found to mediate the most potent effects on the estro-
genic activity of ZEN and α-ZEL.
In order to visualize the impact of AOH on the estro-
genic effects of ZEN and α-ZEL, four exemplary graphs 
were drawn out of the data set. For each Fusarium com-
pound, two line graphs are plotted, showing effects of com-
binations with AOH, in one low (Fig. 2i, ii) and one high 
concentration (Fig. 2iii, iv), in comparison with the effects 
of the single substances.
Combinatory effects of AOH and low concentrations 
of ZEN or α-ZEL (ZEN: concentrations below 100 nM; 
α-ZEL: concentrations below 10 nM) were calculated 
via the combinatory index (CI) and categorized accord-
ing to Chou (2006), regarding synergism or antagonism. 
To enable correct CI calculations, the maximum value for 
AlP activity was set slightly above the maximum measured 
value (3.4 fold induction) compared to the solvent control. 
Due to the special characteristics of dose–response curves 
of all three mycotoxins (discussed below), CI calculations 
of combinations of high concentrations were not applica-
ble. Figure 3 illustrates combinatory effects with CI val-
ues indicated by the color code. Significant differences 
Fig. 3  Heatmaps depicting combinatory effects of binary mixtures 
of AOH with a ZEN or b α-ZEL calculated on basis of AlP activ-
ity. The color code represents combinatory effects evaluated by the 
CI and are categorized according to Chou (2006). Significant dif-
ferences of effects to the solvent control are indicated by asterisks, 
significant differences of the binary mixtures to measurements with 
ZEN or α-ZEL, as single compounds, are indicated by hash marks 
(*, #p > 0.05; **, ##p > 0.01;***, ###p > 0.001). Combinations with 
nonsignificant differences to the effect of 1 nM E2 are highlighted 
in gray and/or framed in blue. All measurements were repeated in at 
least three independent biological replicates, each measured in tech-
nical triplicates (colour figure online)
Fig. 2  Heatmaps showing relative effects on AlP activity of Ishikawa 
cells by single mycotoxins and binary combinations of AOH with a 
ZEN or b α-ZEL (mean, SEM). Effects of solvent control and 1 nM 
E2 were set to 0 and 100 %, respectively. Four line graphs cover-
ing whole concentration ranges of ZEN or α-ZEL in combination 
with one low (i, ii) and one high (iii, iv) concentration of AOH are 
extracted exemplary from the data set for comparison with the effects 
of single substances. Significant differences of effects to the sol-
vent control are indicated by asterisks, significant differences of the 
binary mixtures to measurements with ZEN or α-ZEL, as single com-
pounds, are indicated by hash marks (*, #p > 0.05; **, ##p > 0.01;***, 
###p > 0.001). CI values are indicated by + or −, and reflect catego-
rization of interactions according to Chou (2006). All measurements 
were repeated in at least three independent biological replicates, each 
measured in technical triplicates
◂
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between values of combinations to the respective ZEN or 
α-ZEL concentration tested alone are indicated by hash 
marks. In addition, Fig. 3 shows significant differences of 
single substances and binary combinations, compared to 
the effect of 1 nM E2, indicated by asterisks. Some combi-
nations showed higher effects than E2, while all tested con-
centrations of single substances exhibited significant lower 
effects.
Low concentrations of ZEN (up to 1 nM) in combina-
tions with AOH, at concentrations below 2.5 µM, exhibited 
some antagonistic effects. However, most combinations 
from 1 nM ZEN with AOH were found to have synergis-
tic effects. Synergism was also mediated by the major-
ity of higher concentrated mixtures of AOH and ZEN. A 
very broad concentration range of α-ZEL (1 pM–1 nM) 
was found to have highly synergistic effects in combina-
tion with AOH (see Fig. 3). In both data sets, the majority 
of combinations tested, especially in high doses, were not 
found to be significantly different to the effect of 1 nM E2, 
thus mediating substantial estrogenic effects in the range 
Fig. 4  Measurements of combinations in constant ratios of 1:250 
(ZEN or α-ZEL:AOH) in the AlP assay. a Sigmoidal dose–response 
curve fits of combinations ZEN + AOH and α-ZEL + AOH in com-
parison to dose–response curves of ZEN and α-ZEL alone (mean, 
SEM). b Inhibition of estrogenic effects of highly potent combina-
tions (10 nM ZEN or 10 nM α-ZEL + 2.5 µM AOH) in the AlP assay 
by co-incubation with the ER receptor antagonist ICI 182,780 (mean, 
SEM). Combinatory index (CI) evaluation of constant ratio combina-
tions 1:250 of c α-ZEL + AOH or d ZEN + AOH are represented in 
effect-CI plots (CI < 1 indicates synergism; CI = ~1 indicates addi-
tive effects; CI > 1 indicates antagonism): Dots display CI values of 
measured combinations (a), lines display calculated CI values based 
on medium effect equation (MEE) analysis of the dose–response 
curve of combinations
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of E2. As discussed below, this gives evidence for syner-
gism. To verify whether the very high effects of combina-
tions which reach the effect level of 1 nM E2 depend on 
ER signaling, the highly potent combinations (10 nM ZEN 
or α-ZEL + 2.5 µM AOH) were co-incubated with the 
high-affinity ER inhibitor ICI 182,780. This co-incubation 
leads to complete inhibition of the effects detected for the 
combinations, which demonstrates their ER dependence 
(Fig. 4b)  .
Results on measurements of constant ratio combina-
tions between ZEN or α-ZEL and AOH (1:250) are shown 
in Fig. 4. Sigmoidal dose–response curve fitting was per-
formed for the combinations. According EC50 values and 
concentrations giving 50 % of the effect of E2 are listed in 
Table 2. Evaluation of CI values over the whole effect range 
is presented in the effect-CI plots in Fig. 4c, d and indicates 
mainly synergistic effects between ZEN or α-ZEL and 
AOH. Only at very low concentrations (10 pM + 2.5 nM), 
combinations of α-ZEL and AOH were found to mediate 
antagonism. Similar effects were extrapolated for combina-
tions in very low concentrations of ZEN and AOH based on 
the effect-CI curve.
Impact on cell growth and cytotoxicity
In order to supplement the data on alkaline phosphatase 
stimuli, mycotoxins and binary combinations were tested 
in the SRB assay to assess potential growth stimulatory 
or cytotoxic effects. All experimental conditions were 
kept equal to the AlP activity measurements to enable 
direct comparison of the data sets. Effects of single sub-
stances in the SRB assay are illustrated in Fig. 1d. ZEN 
and α-ZEL showed cell proliferating effects increasing 
with concentration up to 10 µM, whereas ZEN was found 
to be more potent than its metabolite. ZEN even medi-
ated greater growth stimulation than E2 with a significant 
increase of 1.22 fold of total cell protein compared to the 
solvent control. α-ZEL induced significant proliferation at 
100 nM reaching 1.13 fold of total cell protein, compared 
to the control. No cytotoxic effects were observed for both 
Fusarium metabolites at the tested concentrations. AOH 
did not induce proliferation, but was found to be cytotoxic 
at the highest concentrations of 5 and 10 µM. Due to these 
contrary effects on cellular proliferation on the one hand, 
and cytotoxicity on the other hand, it was not reasonable 
to generate curve fits and, more importantly, not possible 
to calculate combinatory effects by the combination index 
theorem (Chou 2006).
Figure 5a, b illustrates heatmaps of all tested combina-
tions and respective data on relative cell protein related to 
the solvent control. In accordance with measurements of 
single compounds, combinations of moderate to high con-
centrations of ZEN (100 nM to 1 µM) and low concentra-
tions of AOH (up to 1 µM) showed proliferative effects, 
whereas such effects could hardly be found in combina-
tions with α-ZEL. Nevertheless, in both data sets for com-
binations at high concentrations of AOH (5 and 10 µM) 
predominantly cytotoxic effects were detected. In order to 
visualize the impact of AOH on the proliferative effects of 
ZEN and α-ZEL, four exemplary graphs were drawn out of 
the data set. For each Fusarium compound, two line graphs 
are plotted showing effects of combinations with AOH in 
low and high concentrations, respectively, as well as the 
effects of the single substances (Fig. 5i–iv).
Discussion
Evaluation of estrogenic effects
Measurements of single mycotoxins confirmed previ-
ous reports that α-ZEL is the most potent estrogen of the 
tested mycoestrogens followed by the parent compound 
ZEN and that AOH possesses comparably low estrogenic 
potency (Frizzell et al. 2011; Hagler et al. 1979; Lehmann 
et al. 2006; Metzler et al. 2010). Comparison of EC50 val-
ues in the AlP assay revealed a clear ranking according to 
estrogenicity as follows: α-ZEL > E2 > ZEN > AOH. How-
ever, these EC50 values depend on the maximum effect 
which can be achieved. This was found to be a substance 
specific property and explains why α-ZEL exerts a lower 
EC50 value than E2 but may, however, not be considered 
as a stronger estrogen. Visual interpretation of the data 
shown in Fig. 1b clearly results in a more reasonable rank-
ing of the substances according to estrogenicity which is 
also reflected by the corresponding concentrations of sub-
stances giving 50 % of the effect of E2 shown in Table 1: 
E2 > α-ZEL > ZEN > AOH. Not only the concentrations at 
Table 2  EC50 values and 
concentrations of constant ratio 
combinations reaching 50 % of 
the effect of E2
a Concentration that gives 50 % of the maximum effect level of each single substance
b Concentration that gives 50 % of the effect of 1 nM E2
EC50a 50 % effect of E2b
ZEN/α-ZEL AOH ZEN/α-ZEL AOH
α-ZEL + AOH 1 : 250 50 pM 12.5 nM 55 pM 13.75 nM
ZEN + AOH 1 : 250 1.241 nM 310.25 nM 865 pM 216.25 nM
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which the substances induced effects but also the maximum 
potency of AlP activation differed among the compounds 
(Fig. 1b). All tested concentrations of α-ZEL, ZEN or AOH 
showed significantly lower effects than E2. These findings 
suggest that α-ZEL, ZEN and AOH act as partial agonists 
in this estrogenic system.
Interestingly, measurements of total cell protein levels in 
the SRB assay did not reflect these findings with respect 
to cell proliferation. Dose–response evaluation in the SRB 
assay of ZEN, as single substance, revealed higher pro-
liferative effects than those caused by α-ZEL or even by 
E2. This was not found in a classical E-screen study using 
MCF7 breast cancer cells (Molina–Molina et al. 2014). 
However, considering that an incubation time of 144 h was 
applied by Molina–Molina et. al., the strong proliferative 
effect of ZEN, found in our study, may depend on differ-
ences in the duration of exposure as well as cell line-spe-
cific responses.
In the present study, the maximum induction of AlP 
measured was not generated by the natural estrogen hor-
mone E2. Several combinations of AOH with ZEN or 
α-ZEL induced higher levels of AlP activity than E2, 
although not statistically significant from the E2 effect 
(p < 0.05). The highest effect was found for the combi-
nation of 10 nM ZEN and 5 µM AOH. Co-incubation of 
highly potent combinations with the ER inhibitor ICI 
182,780 indicated that these strong effects also depend 
on ER signaling. In line with the potency of the single 
compounds, combinations of AOH and α-ZEL showed 
increased AlP activity at much lower concentrations com-
pared to combinations with ZEN. Combinations of α-ZEL 
and AOH in concentrations below 1 nM and 10 µM, respec-
tively, resulted throughout in synergistic effects.
A general principle describes combinatory effects of 
substances that do not interact as simply additive. Accord-
ingly, interactions between compounds are indicated, 
when the combinatory effect is not additive. The combi-
nation index theorem is the mathematical model of first 
choice, which allows quantitative assessment of syner-
gistic or antagonistic effects (Chou 2006). To apply this 
model, effects of single substances and combinations need 
to be described by values between zero and one, standing 
for 0–100 % estrogenic stimulus. However, since α-ZEL, 
ZEN and AOH act as partial antagonists, 100 % of activa-
tion needed to be set to a common value. Therefore, the 
value of 3.4, which lies slightly above the highest measure-
ments obtained during this study, was defined as 100 % AlP 
induction for calculation of the combinatory index (CI). 
Since only relative values are applied here, this approach 
is not expected to have a major impact on the calculation 
of combinatory indices and even minor effects on final con-
clusions, to be drawn from these. However, high concen-
trations of α-ZEL and ZEN, above 1 and 10 nM, respec-
tively, were not included in the calculations, as these would 
falsify the CI calculations of the whole data set, due to 
the partial antagonistic characteristics of the substances. 
Therefore, CI calculation was limited to combinations with 
ZEN below 100 nM and α-ZEL below 10 nM. However, 
considering the fact that the single substances act as partial 
agonist and therefore do not reach the potency of E2, but 
several combinations do, this may be considered as syner-
gism per se. This was demonstrated by statistical analysis, 
which revealed significant differences of effects, of all sin-
gle mycotoxin concentrations to the effect of E2 (thus sig-
nificantly lower than the AlP level reached by E2) that is 
no longer true for several combinations. Summing up these 
results, interactions between AOH and ZEN or α-ZEL were 
found to be synergistic over wide concentration ranges. A 
reasonable explanation for this synergism could be the fact 
that AOH has been reported to predominantly bind ER-β, 
whereas ZEN shows higher affinity to ER-α (Kuiper et al. 
1998; Lehmann et al. 2006). This mechanism seems plausi-
ble since Ishikawa cells are known to express both estrogen 
receptor subtypes (Johnson et al. 2007) and are thus well-
suited for the performed experiments.
Combinations with the two highest concentrations of 
AOH (2.5 and 5 µM) generally showed a decline of estro-
genic effects compared to lower doses although still pro-
ducing a significantly enhanced level of AlP activity. Here, 
cytotoxic effects of the mycotoxins presumably overlapped 
with estrogenic effects, as it was shown by the SRB meas-
urements. The data of the SRB assay, in general, indi-
cated that AOH reduces the proliferative effects of ZEN 
and α-ZEL in a dose dependent manner. In fact, at these 
high concentrations of AOH, of 2.5 and 5 µM, combina-
tions showed slightly cytotoxic effects, which, however, are 
more pronounced in the presence of α-ZEL than of ZEN. 
This reflects the results of cell protein measurements with 
the single substances, which showed that ZEN possesses 
a stronger proliferative potential than α-ZEL under these 
experimental conditions and, therefore, may counteract 
the cytotoxicity of AOH more effectively. Interestingly, the 
reduction of protein amount is not explicitly reflected by a 
dramatic decrease of induction of AlP activity. The fact that 
Fig. 5  Heatmaps showing relative effects on cellular protein amount 
measured by the SRB assay, of single mycotoxins and binary com-
binations of AOH with (a) ZEN or (b) α-ZEL (mean, SEM). Protein 
amount of the solvent control was set to 1. Four line graphs cover-
ing whole concentration ranges of ZEN or α-ZEL in combination 
with one low (i, ii) and one high (iii, iv) concentration of AOH are 
extracted exemplary from the data set for comparison with the effects 
of single substances. Significant differences of effects to the sol-
vent control are indicated by asterisks, significant differences of the 
binary mixtures to measurements with ZEN or α-ZEL, as single com-
pounds, are indicated by a, b or c (*, #p > 0.05; **, ##p > 0.01;***, 
###p > 0.001). All measurements were repeated in at least three inde-
pendent biological replicates, each measured in technical triplicates
◂
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the estrogenic effects on AlP are in general much more pro-
nounced than the proliferative effects may give a reason-
able explanation for this. An experimental setting with 48 h 
of incubation duration may simply be too short to observe 
stronger effects in proliferation in a cell line with a dou-
bling time of 27–36 h (Nishida 2002).
Measurements on constant ratio combinations between 
ZEN or α-ZEL and AOH also revealed, according to the 
CI evaluation, mainly synergistic effects. However, evalu-
ated concentrations of the combinations giving 50 % of 
the effect of E2 did not reveal a shift of the dose–response 
curve α-ZEL when combined with AOH. A slight shift to 
the left could be detected for the curve of ZEN. ZEN alone 
reaches 50 % effect of E2 at 1.423 nM, whereas in combi-
nation with AOH (1:250) this effect is reached at 865 pM 
(+216 nM AOH). Evaluation of combinatory effects 
resulted in quite extreme CI values (Fig. 4c, d), espe-
cially in low effect ranges considering that the data from 
the dose–response curves are reflected (Fig. 4a). It may be 
considered, however, that due to the 1:250 ratio several of 
the combined AOH concentrations are far below the effect 
range of AOH (below 50 nM). Accordingly, only slight 
changes in the low effect ranges might result in calcula-
tions of very strong combinatory effects. Anyhow, for both 
combinations, the evaluated dose–response curves again 
reveal similar effects to what was found previously. The 
maximum effects of the combinations exceed those of ZEN 
and α-ZEL and reach the effect level of E2. As these effects 
were found to depend on ER signaling, they may be con-
sidered as estrogenic synergistic effects per se.
Potential relevance for risk assessment on mixtures 
of mycoestrogens
This study revealed synergistic estrogenic effects of the 
mycotoxin AOH in combination with ZEN or its phase I 
metabolite α-ZEL. Whether these combinations may bear 
endocrine disruptive potential, as it is already known for 
ZEN, still needs to be answered by detailed elucidation 
of potential adverse effects in vivo. However, since myco-
toxins are natural food contaminants, co-exposure of the 
human population seems to be most likely in many settings. 
As a consequence, priority shall be attributed to combina-
tions of mycoestrogens and estrogenic food constituents in 
general. Recently, considerations on combinatory effects 
initiated a paradigm shift in risk assessment of all kinds of 
chemical substances that stipulates mixture effects to be 
included in future (EFSA 2013). This applies to substances 
with all possible modes of action; however, it seems to be 
of special importance for endocrine disruptors. Due to the 
high sensitivity of endocrine systems in general, potential 
effects of compounds might be pronounced even at very 
low concentrations. There are some studies investigating 
the combinatory effects of prominent anthropogenic endo-
crine disruptors like bisphenol-A, phthalates, polychlorin-
ated biphenyls (PCBs) and dioxins, which indicate that 
endocrine effects of mixtures possibly occur below NOELs 
(Couleau et al. 2015; Crofton et al. 2005; Li et al. 2012b). 
Considering co-contamination of food products by several 
substances, human exposure to mixtures seems to be even 
more likely. Our data suggest that also mycoestrogen mix-
tures may lead to adverse effects even at very low concen-
trations due to synergistic interactions. As a consequence, 
current limit values like the tolerable daily intake (TDI) 
for humans or maximum tolerated levels for mycotoxins in 
food may need reconsideration, as they are at present still 
derived from risk evaluation of single substances (EFSA 
2011). Our study highlights the importance of combina-
tory effects to be incorporated in future approaches of risk 
assessment.
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